Evidence map›Paper›PMID 32822428›Full record

ArticlePLoS pathogens2020

Modulation of hepatitis B virus pregenomic RNA stability and splicing by histone deacetylase 5 enhances viral biosynthesis.

Taha Y Taha, Varada Anirudhan, Umaporn Limothai, Daniel D Loeb, Pavel A Petukhov, Alan McLachlan

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. The histone deacetylase family in health and disease.Signal transduction and targeted therapy · 2026
    Review
  2. Article
  3. Article
  4. [Post-transcriptional regulation mechanism and antiviral strategy of hepatitis B virus RNA].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2024
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Taha Y TahaDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, United States of America.ORCID 0000-0002-7344-7490
Varada AnirudhanDepartment of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, Illinois, United States of America.ORCID 0000-0002-5370-1092
Umaporn LimothaiCenter of Excellence in Hepatitis and Liver Cancer, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.ORCID 0000-0003-1521-5592
Daniel D LoebMcArdle Laboratory for Cancer Research, University of Wisconsin - Madison, Madison, Wisconsin, United States of America.
Pavel A PetukhovDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, United States of America.ORCID 0000-0003-1554-242X
Alan McLachlanDepartment of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, Illinois, United States of America.ORCID 0000-0002-4168-2365
University of Illinois Chicago · USChulalongkorn University · THUniversity of Wisconsin–Madison · US

Funding

Developmental regulation of HBV biosynthesis by FoxA and DNA methylationR01AI125401 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MCLACHLAN, ALAN · 2016 to 2020
$2.0M
Liver lobule zonation, hepatocellular carcinoma (HCC) and β-catenin mediated hepatitis B virus (HBV) biosynthesisR01CA238328 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MCLACHLAN, ALAN · 2020 to 2024
$1.8M
Generating Human Cord-Blood-Derived Functional Megakaryocytes and platelets.R01HL130760 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MAHMUD, NADIM, MILLER, WILLIAM M · 2015 to 2018
$1.7M
NCI NIH HHS R01 CA238328NHLBI NIH HHS R01 HL130760NIAID NIH HHS R01 AI125401
6 · The paper itself

Abstract

Hepatitis B virus (HBV) is a worldwide health problem without curative treatments. Investigation of the regulation of HBV biosynthesis by class I and II histone deacetylases (HDACs) demonstrated that catalytically active HDAC5 upregulates HBV biosynthesis. HDAC5 expression increased both the stability and splicing of the HBV 3.5 kb RNA without altering the translational efficiency of the viral pregenomic or spliced 2.2 kb RNAs. Together, these observations point to a broader role of HDAC5 in regulating RNA splicing and transcript stability while specifically identifying a potentially novel approach toward antiviral HBV therapeutic development.

Indexed as

Genome, ViralRNA StabilityGene Expression Regulation, ViralHepatitis BHepatitis B virusHep G2 CellsHistone DeacetylasesHumansRNA, ViralTranscription, GeneticVirus ReplicationHistone DeacetylasesRNA, Viral

Identifiers

PMID32822428
PMCPMC7467325
OpenAlexW3080559332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.